Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Effects of IL-1β and Its Receptor Antagonists in the Treatment of Severe Infection and Inflammatory Storm in Children

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04821414
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:36.897652+00:00
Published At
2022-06-15T00:00:00+00:00
Record Updated At
2022-06-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Critical Illness", "Sepsis, Severe"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-06-15"
protocolSection.identificationModule.nctId
"NCT04821414"
protocolSection.identificationModule.officialTitle
"Effects of IL-1\u03b2 and Its Receptor Antagonists in the Treatment of Severe Infection and Inflammatory Storm in Children"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Critical Illness (protocolSection.conditionsModule.conditions)
  • Sepsis, Severe (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.